Health products policy and standards
Our team provides authoritative guidance and standards on quality, safety and efficacy of health products and supports countries to formulate evidence-based policies and ensure good practice throughout the value chain.
Expert Committees
Advisory groups
Publications
All →
28 August 2025
Good practices for blood establishments
Blood transfusion is a vital component of modern health care and can be life-saving in many clinical situations. However, it is not without risks, including...
14 May 2025
WHO guideline on balanced national controlled medicines policies to ensure medical access and safety:...
WHO recommends that essential medicines, including those that are controlled, be available to all patients at all times at a price that the individual...
23 April 2025
Guidance on implementing patient blood management to improve global blood health status
Incorporating expertise from peers working in countries where health care faces extreme resource constraints, attention is paid to how PBM processes...
16 April 2025
WHO Drug Information - Volume 39, No. 1
The first issue of volume 39 for 2025 includes:Consultation Documents: - "Aminosalicylate sodium dihydrate (aminosalicylatum natricum dihydricus)"- "Aminosalicylate...
Journal articles
WHO implementation workshop on guidelines on procedures and data requirements for changes to approved biotherapeutic products: Seoul, Republic of Korea, 25–26 June 2019
Biologicals Volume 65, May 2020, Pages 50-59
WHO informal consultation on development of guidelines on procedures and data requirements for changes to approved biotherapeutic products: Seoul, Republic of Korea, 27–28 April 2017
Biologicals, Volume 52, March 2018, Pages 83-91
1st WHO International Standard antiserum to RSV: Availability and benefits for RSV vaccine development: Commentary on the collaborative study report published in the vaccine journal (Vaccine 2018 36: 7641-7649)
Vaccine, 2019 Jul 18; 37(31):4233-4235
